![Pawel Krysiak](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Cuong Viet Do | M | 58 |
M6P Therapeutics
![]() M6P Therapeutics BiotechnologyHealth Technology M6P Therapeutics is a biotechnology company that develops targeted recombinant enzyme and gene therapies for lysosomal storage disorders. M6P Therapeutics is based in St. Louis, MO and their mission is to translate advanced science into therapies that address unmet needs within the LSD community. The private company's proprietary bicistronic-s1s3 platform enhances phosphorylation of lysosomal enzymes for both recombinant enzyme and gene therapies, leading to improved biodistribution and cellular uptake of recombinant proteins and efficient cross-correction of gene therapy product. The company was founded in 2017 by Cuong Viet Do, Stuart Kornfeld, Lin Liu, and the CEO is Pawel Krysiak. | 7 years |
Connections Chart
Multi-company connection
Statistics
Country | Connections | % of total |
---|---|---|
United States | 1 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Pawel Krysiak
- Personal Network